1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. United States >
  6. Arbor Pharmaceuticals >
  7. M&A

Arbor Pharmaceuticals Mergers & Acquisitions

Arbor Pharmaceuticals M&A Summary

Arbor Pharmaceuticals has acquired 1 company of its own.

Arbor Pharmaceuticals’ largest acquisition to date was in 2016, when it acquired XenoPort for $467M. Arbor Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Arbor Pharmaceuticals

Arbor Pharmaceuticals LLC

Six Concourse Parkway, Suite 1800,
Atlanta, Georgia 30328
United States,
(678) 334-2420
www.arborpharma.com

All (1) Buy (1) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2016-05-23 XenoPort, Inc. · Life Science
Redwood City, California · www.xenoport.com

XenoPort, Inc. is a biopharmaceutical company focused on commercializing HORIZANT in the United States. XenoPort has entered into a clinical trial agreement with the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under which the NIAAA has initiated a clinical trial evaluating HORIZANT as a potential treatment for patients with alcohol use disorder.

Revenue (mlns) 41 USD
Advisors: Centerview Partners , Weil Gotshal & Manges 		467
11.3x REVENUE 		Add-on Acquisition

Arbor Pharmaceuticals
Advisors: Alston & Bird , Deutsche Bank Corporate & Investment Banking , Simpson Thacher & Bartlett

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal